Published: Jun 15, 2021, 23:45 IST | Updated: Jun 15, 2021, 23:45 IST
In a new study, a research team led by Dr. Tracey Rouault in the US National Institute of Child Health and Human Development (NICHD) has found new ways to target an enzyme produced by SARS-CoV-2 called RNA-dependent RNA polymerase (RdRp).